US Drug Recall Register

FDA Drug Recalls

14,801 recalls, newest first

Class II · Moderate risk Terminated

Arnica 7 Cream

Reason cGMP deviations

Homeocare Laboratories, Inc. D-0881-2023
Class I · High risk Terminated

ZIPRASIDONE HYDROCHLORIDE CAPSULES 20 mg

Reason Labeling: Label Mix-up: Unit Dose cartons labeled as Ziprasidone Hydrochloride Capsules, 20 mg were found to contain blister packages labeled as and containing Dronabinol Capsules, USP, 2.5 mg.

The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories NDC 0904-6269-08 D-0893-2023
Class II · Moderate risk Terminated

Extended Phenytoin Sodium Capsules

Reason Failed Dissolution Specifications: Out-of-specification results for dissolution (above specification)

Amneal Pharmaceuticals of New York, LLC NDC 65162-212-10 D-0876-2023
Class II · Moderate risk Terminated

Travoprost Ophthalmic Solution

Reason Lack of Assurance of Sterility: Tamper Evidence Seal is missing on secondary container.

Golden State Medical Supply Inc. NDC 51407-731-25 D-0867-2023
Class II · Moderate risk Terminated

Levsin injection

Reason CGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.

Viatris Inc NDC 0037-9001-05 D-0866-2023
Class II · Moderate risk Terminated

Sodium Chloride 0.9% Injection

Reason Lack of assurance of sterility: The product was potentially exposed to below-recommended storage temperatures, which may cause leaks in the packaging.

Fresenius Medical Care Holdings, Inc. NDC 49230-300-10 D-0777-2023
Class III · Low risk Terminated

Glycopyrrolate Tablets

Reason Failed Impurities/Degradation Specifications

Aurolife Pharma, LLC NDC 13107-014-01 D-0877-2023
Class II · Moderate risk Terminated

Foaming Hand Sanitizer

Reason CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.

Alpha Aromatics D-0760-2023
Class II · Moderate risk Terminated

Ceftriaxone for Injection

Reason Lack of Assurance of Sterility

Astral SteriTech Private Ltd. NDC 70594-098-01 D-0620-2023
Class II · Moderate risk Terminated

Ceftriaxone for Injection

Reason Lack of Assurance of Sterility

Astral SteriTech Private Ltd. NDC 70594-097-02 D-0619-2023